[ Price : $8.95]
Federal Register Notice: FDA seeks comments on a collection of information associated with adverse event reporting and recordkeepi...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on information collection associated with processes for stakeholders to request additi...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on a collection of information on device inspections by accredited persons.[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance: Manufacturing Site Change Supplements: Content and Submission.[ Price : $8.95]
Federal Register Final order: FDA classifies the coronary vascular physiologic simulation software device into Class 2.[ Price : $8.95]
FDA clears 23andMes Personal Genome Service, a controversial genetic test that was as the center of a CDRH regulatory action two y...[ Price : $8.95]
Friends of Cancer Research founder Helen Sigal says FDAs regulatory framework for drugs and devices needs to be updated to reflect...[ Price : $8.95]
FDA issues a draft guidance revising definitions for packaging types and adding a new definition.